Showing 11-20 of 40 results for "".
- Adding New Personalized Vaccine to Immunotherapy Slashes Risk for Melanoma Recurrencehttps://practicaldermatology.com/news/adding-new-personalized-vaccine-to-immunotherapy-slashes-risk-for-melanoma-recurrence/2461662/Adding an experimental mRNA vaccine to immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% when compared with immunotherapy alone, a new clinical trial shows. The phase 2b trial results were presented at the annual meeting of the American Association for Cancer Rese…
- Dr. Susan C. Taylor Elected 2025 AAD Presidenthttps://practicaldermatology.com/news/dr-susan-c-taylor-elected-2025-aad-president/2461653/Susan C. Taylor, MD, FAAD is the American Academy of Dermatology’s president-elect. She will be installed in March 2024 and hold the office of president for one year beginning in March 2025. Dr. Taylor previously served as AAD Vice President from 2020 – 2021. She is the Bernett Johnson Professor …
- Study: Plugging Immune Cell Leakage from Tumors Could Improve MelanomaTreatmenthttps://practicaldermatology.com/news/study-plugging-immune-cell-leakage-from-tumors-could-improve-melanomatreatment/2461578/The number of specialized immune cells available for fighting skin cancer double when a new treatment blocks their escape from melanoma tumors, according to new research out of NYU Langone Health’s Perlmutter Cancer Center Combining a chemical blocker of immune cell exit with an immunotherapy drug…
- NEA Announces 2022 Research Grant Recipientshttps://practicaldermatology.com/news/nea-announces-2022-research-grant-recipients/2461457/The National Eczema Association (NEA) announced the recipients for its 2022 research grants. From both U.S.-based and international applications, the research projects of 13 investigators were selected, representing grants totaling nearly $730,000. 2022 marked a significant jump in NEA's investmen…
- Nevisense Boosts Clinician Confidence in Early Melanoma Diagnosishttps://practicaldermatology.com/news/nevisense-boosts-clinicians-confidence-in-early-melanoma-diagnosis/2461053/Nevisense provides valuable diagnostic guidance for clinicans when evaluating atypical pigmented skin lesions, according to a new study. The Nevisense method uses small electrical impulses to detect cellular irregularities beneath the skin’s surface. In the pilot study, mean confidence for clinic…
- Practical Dermatology Magazine Mourns the Passing of Two Preeminent Dermatologistshttps://practicaldermatology.com/news/practical-dermatology-mourns-the-passing-of-two-preeminent-dermatologists/2460741/By Wendy Lewis It is with great sadness that Practical Dermatology® magazine pays our respects to two very talented and respected dermatologists, Melanie Grossman, MD and Marta Rendon, MD. Melanie Grossman, MD 1962 - 2021 Dr. Grossman was a trailblazer in her field and among the first female d…
- AccuTec Blades: New Catalog Launches AccuThrive Brandhttps://practicaldermatology.com/news/accutec-blades-new-catalog-launches-accuthrive-brand/2460719/Introducing the newAccuThrive® medical brand, AccuTec Blades® Inc. has published its 2021 histology catalog. The 2021 AccuThrive blades portfolio highlights a new line of microtome and gross dissection blades engineered via a proprietary grinding, heat treating, and coating formula that produces co…
- COVID-19, the Stock Market, and Dermatologyhttps://practicaldermatology.com/news/covid-19-the-stock-market-and-dermatology/2460688/By Amylee Martin, BS, Akshitha Thatiparthi, BS, Jeffrey Liu, BS, Jashin J. Wu, MD Novel coronavirus, COVID-19, is not only a major public health threat but has also impacted the economy. Due to the pandemic, experts predict a 0.5% decrease in the global gross domestic product growth during 20…
- Second-Draw PPP Loans: What Dermatologists Should Knowhttps://practicaldermatology.com/news/second-draw-ppp-loans-what-dermatologists-should-know/2460680/By Mark Schmidt, CEO, Fund-Ex Solutions Group Dermatologists have proven their resiliency throughout the pandemic, and now more help is here with another round of funding through the Paycheck Protection Program (PPP). The Economic Aid Act reopened the Small Business Administration’s PPP, and appli…
- DermTech Closes Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shareshttps://practicaldermatology.com/news/dermtech-closes-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/2460651/DermTech, Inc. closed its previously announced underwritten public offering of 4,872,881 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase up to 635,593 additional shares, at a price to the public of $29.50 per share, the company reports…